Loading clinical trials...
Loading clinical trials...
Phase 2 Study to Assess Safety & Tolerability of a Single Injection Into the Knee Joint of Two Different Doses of MSB-CAR001 Combined With Hyaluronan Compared to Hyaluronan Alone in Patients Who Have Undergone an ACL Reconstruction
Conditions
Interventions
MSB-CAR001 Combined With Hyaluronan
Hyaluronan
Locations
1
Australia
Emeritus Research
Malvern East, Victoria, Australia
Start Date
March 1, 2009
Primary Completion Date
November 1, 2013
Completion Date
October 1, 2014
Last Updated
August 15, 2018
NCT07217405
NCT07551245
NCT06755697
NCT06702046
NCT05986292
NCT06381791
Lead Sponsor
Mesoblast, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions